Introduction: Although the prevalence of chronic kidney disease (CKD) is increasing in the aging population, the clinical relevance of the CKD definition (glomerular filtration rate [GFR] <60 mL/min/1.73 m2) in older populations remains debatable. We investigated the clinical outcomes in older populations with mildly to moderately decreased GFR (45–59 mL/min/1.73 m2, CKD stage 3A). Methods: A total of 7,789,242 participants aged ≥40 years with estimated GFR (eGFR) ≥45 mL/min/1.73 m2 in national health screening examination from 2012 to 2017 were included in this retrospective cohort study using the Korean National Health Insurance Service database. The main outcomes included kidney failure, cardiovascular disease (CVD), and all-cause death. Cox regression hazard models were used to estimate the hazard ratios. Results: The proportion of participants with eGFR 45–59 mL/min/1.73 m2 was 10.0% and 16.3% in the old (65–74 years) and very old (75≥ years) groups, respectively. Mildly to moderately decreased eGFR was associated with a higher risk of kidney failure, CVD, and all-cause death compared with eGFR 60–89 mL/min/1.73 m2 in the old and very old groups, regardless of proteinuria (adjusted hazard ratio [95% confidence interval] in the very old group without proteinuria: kidney failure 3.048 [2.495–3.722], CVD 1.103 [1.066–1.142], and all-cause death 1.172 [1.144–1.201]). Conclusion: Mildly to moderately decreased eGFR was associated with an increased risk of kidney failure, CVD, and all-cause death in the older population, regardless of proteinuria, suggesting the importance of appropriate monitoring and management in this population.

Chronic kidney disease (CKD) is diagnosed when the glomerular filtration rate (GFR) falls below 60 mL/min/1.73 m2. While it is normal for GFR to decrease with age, this threshold remains important for diagnosing CKD in older adults. Our research shows that even people aged 75 and older with a GFR between 45 and 59 mL/min/1.73 m2 (CKD stage 3A) have higher risks of kidney failure, myocardial infarction or stroke, and death. This suggests that it may be reasonable to define CKD using a GFR below 60 mL/min/1.73 m2 even in older adults. Therefore, older adults with slightly reduced GFR need regular checkups and careful management to prevent complications. Despite the natural decline of GFR with aging, defining CKD as a GFR below 60 mL/min/1.73 m2 helps ensure that older adults with mildly to moderately decreased GFR are properly monitored and managed to prevent serious health issues and improve overall quality of life.

1.
Kovesdy
CP
.
Epidemiology of chronic kidney disease: an update 2022
.
Kidney Int Suppl
.
2022
;
12
(
1
):
7
11
.
2.
Lutz
W
,
Sanderson
W
,
Scherbov
S
.
The coming acceleration of global population ageing
.
Nature
.
2008
;
451
(
7179
):
716
9
.
3.
Coresh
J
,
Selvin
E
,
Stevens
LA
,
Manzi
J
,
Kusek
JW
,
Eggers
P
, et al
.
Prevalence of chronic kidney disease in the United States
.
JAMA
.
2007
;
298
(
17
):
2038
47
.
4.
Go
AS
,
Chertow
GM
,
Fan
D
,
McCulloch
CE
,
Hsu
CY
.
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
.
N Engl J Med
.
2004
;
351
(
13
):
1296
305
.
5.
Levin
A
,
Stevens
PE
,
Bilous
RW
,
Coresh
J
,
De Francisco
AL
,
De Jong
PE
, et al
.
Kidney disease: Improving global outcomes (kdigo) ckd work group. Kdigo 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
.
Kidney Int supplements
.
2013
;
3
(
1
):
1
150
.
6.
Wesson
L
.
Renal hemodynamics in physiologic state
.
Physiol Hum kidney
.
1969
:
96
108
.
7.
O’Sullivan
ED
,
Hughes
J
,
Ferenbach
DA
.
Renal aging: causes and consequences
.
J Am Soc Nephrol
.
2017
;
28
(
2
):
407
20
.
8.
Davies
DF
,
Shock
NW
.
Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males
.
J Clin Invest
.
1950
;
29
(
5
):
496
507
.
9.
Bäck
SE
,
Ljungberg
B
,
Nilsson-Ehle
I
,
Borgå
O
,
Nilsson-Ehle
P
.
Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males
.
Scand J Clin Lab Invest
.
1989
;
49
(
7
):
641
6
.
10.
Fenton
A
,
Montgomery
E
,
Nightingale
P
,
Peters
AM
,
Sheerin
N
,
Wroe
AC
, et al
.
Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation
.
BMC Nephrol
.
2018
;
19
(
1
):
336
.
11.
Stengel
B
,
Metzger
M
,
Froissart
M
,
Rainfray
M
,
Berr
C
,
Tzourio
C
, et al
.
Epidemiology and prognostic significance of chronic kidney disease in the elderly--the three-city prospective cohort study
.
Nephrol Dial Transpl
.
2011
;
26
(
10
):
3286
95
.
12.
Delanaye
P
,
Jager
KJ
,
Bökenkamp
A
,
Christensson
A
,
Dubourg
L
,
Eriksen
BO
, et al
.
Ckd: a call for an age-adapted definition
.
J Am Soc Nephrol
.
2019
;
30
(
10
):
1785
805
.
13.
Hallan
SI
,
Matsushita
K
,
Sang
Y
,
Mahmoodi
BK
,
Black
C
,
Ishani
A
, et al
.
Age and association of kidney measures with mortality and end-stage renal disease
.
JAMA
.
2012
;
308
(
22
):
2349
60
.
14.
Chronic Kidney Disease Prognosis Consortium
;
Matsushita
K
,
van der Velde
M
,
Astor
BC
,
Woodward
M
,
Levey
AS
, et al
.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
.
Lancet
.
2010
;
375
(
9731
):
2073
81
.
15.
Musso
CG
,
Oreopoulos
DG
.
Aging and physiological changes of the kidneys including changes in glomerular filtration rate
.
Nephron Physiol
.
2011
;
119
(
Suppl 1
):
p1
5
.
16.
Denic
A
,
Glassock
RJ
,
Rule
AD
.
The kidney in normal aging: a comparison with chronic kidney disease
.
Clin J Am Soc Nephrol
.
2022
;
17
(
1
):
137
9
.
17.
Park
S
,
Cho
S
,
Lee
S
,
Kim
Y
,
Park
S
,
Kim
YC
, et al
.
The prognostic significance of body mass index and metabolic parameter variabilities in predialysis ckd: a nationwide observational cohort study
.
J Am Soc Nephrol
.
2021
;
32
(
10
):
2595
612
.
18.
Park
J
,
Shin
DW
,
Han
K
,
Kim
D
,
Chun
S
,
Jang
HR
.
Associations between kidney function, proteinuria, and the risk of kidney cancer: a nationwide cohort study involving 10 million participants
.
Am J Epidemiol
.
2021
;
190
(
10
):
2042
52
.
19.
Jung
W
,
Park
J
,
Jang
HR
,
Jeon
J
,
Han
K
,
Kim
B
, et al
.
Increased end-stage renal disease risk in age-related macular degeneration: a nationwide cohort study with 10-year follow-up
.
Sci Rep
.
2023
;
13
(
1
):
183
.
20.
Shin
DW
,
Cho
J
,
Park
JH
,
Cho
B
.
National general health screening program in korea: history, current status, and future direction
.
Precis Future Med
.
2022
;
6
(
1
):
9
31
.
21.
Levey
AS
,
Coresh
J
,
Greene
T
,
Stevens
LA
,
Zhang
YL
,
Hendriksen
S
, et al
.
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
.
Ann Intern Med
.
2006
;
145
(
4
):
247
54
.
22.
Bae
EH
,
Lim
SY
,
Kim
B
,
Oh
TR
,
Song
SH
,
Suh
SH
, et al
.
Effects of blood pressure according to age on end-stage renal disease development in patients with diabetes: a nationwide population-based cohort study
.
Hypertension
.
2022
;
79
(
8
):
1765
76
.
23.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
3rd
,
Feldman
HI
, et al
.
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009
;
150
(
9
):
604
12
.
24.
Delanaye
P
,
Glassock
RJ
,
Pottel
H
,
Rule
AD
.
An age-calibrated definition of chronic kidney disease: rationale and benefits
.
Clin Biochem Rev
.
2016
;
37
(
1
):
17
26
.
25.
Muntner
P
,
Bowling
CB
,
Gao
L
,
Rizk
D
,
Judd
S
,
Tanner
RM
, et al
.
Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality
.
Clin J Am Soc Nephrol
.
2011
;
6
(
9
):
2200
7
.
26.
Weisbord
SD
,
Fried
LF
,
Arnold
RM
,
Fine
MJ
,
Levenson
DJ
,
Peterson
RA
, et al
.
Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients
.
J Am Soc Nephrol
.
2005
;
16
(
8
):
2487
94
.
27.
Chen
SS
,
Al Mawed
S
,
Unruh
M
.
Health-related quality of life in end-stage renal disease patients: how often should we ask and what do we do with the answer
.
Blood Purif
.
2016
;
41
(
1–3
):
218
24
.
28.
Florea
A
,
Jacobs
ET
,
Harris
RB
,
Klimentidis
YC
,
Thajudeen
B
,
Kohler
LN
.
Chronic kidney disease unawareness and determinants using 1999-2014 national health and nutrition examination survey data
.
J Public Health
.
2022
;
44
(
3
):
532
40
.
29.
Lefebvre
C
,
Hindié
J
,
Zappitelli
M
,
Platt
RW
,
Filion
KB
.
Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
.
Clin Kidney J
.
2020
;
13
(
1
):
63
71
.
30.
Lewis
EJ
,
Hunsicker
LG
,
Clarke
WR
,
Berl
T
,
Pohl
MA
,
Lewis
JB
, et al
.
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
.
N Engl J Med
.
2001
;
345
(
12
):
851
60
.
31.
Hou
FF
,
Zhang
X
,
Zhang
GH
,
Xie
D
,
Chen
PY
,
Zhang
WR
, et al
.
Efficacy and safety of benazepril for advanced chronic renal insufficiency
.
N Engl J Med
.
2006
;
354
(
2
):
131
40
.
32.
Winkelmayer
WC
,
Zhang
Z
,
Shahinfar
S
,
Cooper
ME
,
Avorn
J
,
Brenner
BM
.
Efficacy and safety of angiotensin ii receptor blockade in elderly patients with diabetes
.
Diabetes Care
.
2006
;
29
(
10
):
2210
7
.
33.
Mann
JF
,
Schmieder
RE
,
Dyal
L
,
McQueen
MJ
,
Schumacher
H
,
Pogue
J
, et al
.
Effect of telmisartan on renal outcomes: a randomized trial
.
Ann Intern Med
.
2009
;
151
(
1
):
1
W2
.
34.
O’Hare
AM
,
Kaufman
JS
,
Covinsky
KE
,
Landefeld
CS
,
McFarland
LV
,
Larson
EB
.
Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin ii-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults
.
Ann Intern Med
.
2009
;
150
(
10
):
717
24
.
35.
Astor
BC
,
Levey
AS
,
Stevens
LA
,
Van Lente
F
,
Selvin
E
,
Coresh
J
.
Method of glomerular filtration rate estimation affects prediction of mortality risk
.
J Am Soc Nephrol
.
2009
;
20
(
10
):
2214
22
.
36.
Donfrancesco
C
,
Palleschi
S
,
Palmieri
L
,
Rossi
B
,
Lo Noce
C
,
Pannozzo
F
, et al
.
Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the matiss study
.
PLoS One
.
2013
;
8
(
10
):
e78475
.
37.
Tian
S
,
Xu
Y
.
Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies
.
Geriatr Gerontol Int
.
2016
;
16
(
2
):
155
66
.
38.
Abramowitz
MK
,
Hall
CB
,
Amodu
A
,
Sharma
D
,
Androga
L
,
Hawkins
M
.
Muscle mass, bmi, and mortality among adults in the United States: a population-based cohort study
.
PLoS One
.
2018
;
13
(
4
):
e0194697
.
39.
Park
M
,
Yoon
E
,
Lim
YH
,
Kim
H
,
Choi
J
,
Yoon
HJ
.
Renal hyperfiltration as a novel marker of all-cause mortality
.
J Am Soc Nephrol
.
2015
;
26
(
6
):
1426
33
.
40.
Moriconi
D
,
Sacchetta
L
,
Chiriacò
M
,
Nesti
L
,
Forotti
G
,
Natali
A
, et al
.
Glomerular hyperfiltration predicts kidney function decline and mortality in type 1 and type 2 diabetes: a 21-year longitudinal study
.
Diabetes Care
.
2023
;
46
(
4
):
845
53
.
41.
Park
J
,
Kwon
S
,
Choi
E-K
,
Choi
Y-J
,
Lee
E
,
Choe
W
, et al
.
Validation of diagnostic codes of major clinical outcomes in a national health insurance database
.
Int J Arrhythmia
.
2019
;
20
(
1
):
5
7
.
42.
Derose
SF
,
Rutkowski
MP
,
Crooks
PW
,
Shi
JM
,
Wang
JQ
,
Kalantar-Zadeh
K
, et al
.
Racial differences in estimated gfr decline, esrd, and mortality in an integrated health system
.
Am J Kidney Dis
.
2013
;
62
(
2
):
236
44
.
You do not currently have access to this content.